Tjeerd Homsma, TripleMed - Revolutionizing Aortic Aneurysm Treatment | LSI Europe '24

TripleMed aims to develop innovative and cost-effective solutions for the treatment of aortic aneurysms.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Tjeerd Homsma
Tjeerd Homsma
CEO, TripleMed